Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
The paper analyzes the use of movalis (meloxicam) in 150 patients with nonspecific back pain in the outpatient setting. Movalis was given in a single daily oral dose of 15 mg throughout the follow-up; the oral use of the drug was, if required, preceded by a 3-day course of its intramuscular administ...
Main Authors: | O. N. Gerasimova, V. A. Parfenov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2011-12-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/102 |
Similar Items
-
Clinical experience with meloxicam (Movalis®) in nonspecific back pain and radiculopathy
by: O N Gerasimova, et al.
Published: (2012-06-01) -
TREATMENT FOR ACUTE NONSPECIFIC BACK PAIN IN OUTPATIENT PRACTICE
by: O. N. Gerasimova, et al.
Published: (2009-12-01) -
The issues of safety and pharmacoeconomics in the management of chronic pain in the back and limbs
by: Vladimir Anatol'evich Parfenov, et al.
Published: (2011-06-01) -
The issues of safety and pharmacoeconomics in the management of chronic pain in the back and limbs
by: Vladimir Anatol'evich Parfenov, et al.
Published: (2011-06-01) -
Issues of safety and pharmacoeconomics in the treatment of chronic pain in the back and limbs
by: V. A. Parfenov, et al.
Published: (2011-06-01)